Geneva Partners’s Northrop Grumman NOC Stock Holding History

Geneva Partners’s Portfolio NOC Stock Details NOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,138	Closed	-$1.17M	–	69
2022 Q4	$1.17M	Buy	+2,138	New	+$1.12M	1.1%	29

Other funds holding NOC

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geneva Partners's NOC Position: Q1 2023 in Review

Geneva Partners sold out of Northrop Grumman (NOC) in Q1 2023, closing a stake of 2,138 shares — an estimated $1.17M sold.

Geneva Partners first reported a position in NOC in Q4 2022 and held it in 1 quarter. The position peaked at $1.17M in Q4 2022. 1,414 funds tracked by Wall St. Rank hold NOC as of Q1 2023.

Geneva Partners reported no remaining Northrop Grumman position as of Q1 2023 after selling out during the quarter.
Geneva Partners sold 2,138 Northrop Grumman shares in Q1 2023, an estimated $1.17M.
Geneva Partners first reported a position in Northrop Grumman in Q4 2022 and held it in 1 quarter.
Geneva Partners's Northrop Grumman position peaked at $1.17M in Q4 2022.
1,414 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2023.

Based on Geneva Partners's 13F filing for Q1 2023, filed 26 Apr 2023.